Skip to main content

Table 3 Effects of various compounds on the secretion of TNF-α (pg/mL) in LPS-stimulated (pre-treatment) thioglycolate-elicited peritoneal macrophages of 8-week-old BALB/c female mice1

From: Suppression of nitric oxide induction and pro-inflammatory cytokines by novel proteasome inhibitors in various experimental models

 

Pre-treatment

  

Secretion of TNF-α (pg/mL)

   

#

Assay Mixture

Dexamethasone

Mevinolin

α,-Tocopherol

δ-Tocotrienol*

Riboflavin

Quercetin

1

Media + Cells = A

      

2

A + LPS (10 ng/mL) = B

1224

1224

1224

1224

1224

1224

3

B + 0.2% DMSO2 = C

1305 (100)3

1305 (100)3

1305 (100)3

1305 (100)3

1305 (100)3

1305 (100)3

4

C + 5 μM

333 (26)

1125 (86)

1280 (98)

938 (72)

1012 (76)

980 (75)

5

C + 10 μM

283 (22)

1064 (82)

1267 (97)

962 (74)

896 (69)

873 (67)

6

C + 20 μM

234 (18)

1012 (78)

1235 (95)

834 (64)

674 (52)

846 (65)

7

C + 40 μM

213 (16)

1048 (80)

1259 (96)

769 (59)

621 (48)

821 (63)

8

C + 80 μM

207 (16)

1140 (87)

1298 (99)

1673 (128)

544 (42)

778 (60)

9

C + 160 μM

133 (10)

1396 (107)

1323 (101)

1732 (133)

520 (40)

472 (36)

10

C + 320 μM

112 (9)

1443 (111)

1257 (96)

1987 (152)

480 (37)

345 (26)

11

C + 640 μM

85 (7)

1487 (114)

1241 (95)

2245 (172)

406 (31)

310 (24)

  1. 1The thioglycolate-elicited peritoneal macrophages (1.0 mL) were adhered to the bottom of 12 well plates (1 × 107 cells/well in 1.0 mL media) for 4 h, then cells were washed extennsively with medium 3-times. Then cells were cultured overnight in fresh media. After overnight incubation at 37°C in an incubator at 5% CO2 for 1 h, then cells were treated with different concentrations of various compounds for 1 h. after 1 h, LPS (10 μL of 1.0 μg/mL stock solution) was added to each well (LPS final concentration 10.0 ng/mL). The supernatants were collected after 4 h of incubation at room temperature. The supernatants were collected after 4 h of LPS challenge, and stored at -70°C to carry out TNF- α ELISA assay. Cells viability were > 95% in all treatments.
  2. 2Each compound was dissolved in dimethyl sulfoxide (0.2% DMSO). Appropriate amount of each compound (highest concentration) was dissolved in 1.0 mL DMSO = A stock solution; 50 μL of stock solution A was mixed with 950 μL of media = B working solution. The remaining concentrations were prepared from B working solution (1:2 dilution) successively.
  3. 3Percentages of control values are in parenthesis.
  4. *Values from reference [10] in Lipids in Health and Disease 2011,10: 39.